Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alogliptin vs Glipizide in Type 2 Diabetes
NCT00856284Phase 3Completed
- Sponsor
- Takeda
- Start
- Mar 2009
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 32
01
Overview
A Phase 3 trial of alogliptin in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Mar 2009; status: completed.
02
Drugs
alogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00856284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00856284.